EUVIMEDEUVIMED entdecken
Open Access

Age-, sex-, and ancestry-specific prevalence of hearing loss in UK Biobank and All of Us Research Program

Jun He, Sharon G Curhan, Gary C Curhan, Renato Polimanti

aging and disease · 2025

DOI: 10.14336/ad.2025.0754 ↗

Kurz gefasst

Fachartikel in der Zeitschrift aging and disease, 2025. Verfasst von Jun He und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Psychiatry, Yale University School of Medicine, New Haven, CT 06510, USA. Hauptthemen laut MEDLINE: Hearing Loss, Population Groups. Die Arbeit wurde bisher 2-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIH HHS, NIDCD NIH HHS, NIMH NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Hearing loss (HL) is a leading cause of global disease burden, but limited information is available regarding differences among individuals of diverse ancestral backgrounds. Here, we assessed age-, sex-, and ancestry-specific prevalence of HL in 827 406 participants from UK Biobank (UKB, N = 448 193) and All of Us Research Program (AoU, N = 379 213). HL was defined based on electronic health records and self-reported information, and HL prevalence was calculated for each subgroup. Age trends and prevalence differences between sexes and ancestries were tested. Age-standardized prevalence was computed for UKB and AoU using the combined sample size of the two cohorts as the standard population. The overall HL prevalence was 28% in UKB (24% in females; 34% in males) and 16% in AoU (13% in females; 20% in males). Sex differences were statistically significant across all age groups in UKB, and among participants aged >55 years in AoU. Across ancestry groups, males had a higher prevalence of HL than females, except for those of African descent in the AoU sample (10% in females and 9.5% in males). The ancestry-specific prevalence was highest among those of European descent in both UKB (29%) and AoU (20%), and lowest among those of African descent (12%) in UKB and Central/South Asian descent (7.3%) in AoU. The HL polygenic risk score was associated with HL in both female and male samples. Overall, this study provides comprehensive evidence that sex differences in HL prevalence should be considered in the context of population diversity.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hearing LossPopulation GroupsAdultAgedFemaleHumansMaleMiddle AgedAge FactorsBiological Specimen BanksPrevalenceSex FactorsUK BiobankUnited KingdomUnited States

Autor:innen und Institutionen

  • Department of Psychiatry, Yale University School of Medicine, New Haven, CT 06510, USA.
  • Veteran Affairs Connecticut Healthcare System, West Haven, CT 06516, USA.
  • Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital, Boston, MA 02115, USA.
  • Department of Medicine, Harvard Medical School, Boston, MA 02115, USA.
  • Department of Chronic Disease Epidemiology, Yale School of Public Health, New Haven, CT 06511, USA.
  • Wu Tsai Institute, Yale University, New Haven, CT 06511, USA.

Förderung

  • NIH HHS
  • NIDCD NIH HHS
  • NIMH NIH HHS

Zitieren

APA

He, J., Curhan, S. G., Curhan, G. C., & Polimanti, R. (2025). Age-, sex-, and ancestry-specific prevalence of hearing loss in UK Biobank and All of Us Research Program. aging and disease. https://doi.org/10.14336/ad.2025.0754

Vancouver

He J, Curhan SG, Curhan GC, Polimanti R. Age-, sex-, and ancestry-specific prevalence of hearing loss in UK Biobank and All of Us Research Program. aging and disease. 2025. doi:10.14336/ad.2025.0754

BibTeX
@article{He2025,
  author = {He, Jun and Curhan, Sharon G and Curhan, Gary C and Polimanti, Renato},
  title = {Age-, sex-, and ancestry-specific prevalence of hearing loss in UK Biobank and All of Us Research Program},
  journal = {aging and disease},
  year = {2025},
  doi = {10.14336/ad.2025.0754}
}
Kostenlos starten →